Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T22:46:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows an updated Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor platform update to the study details page.
    Difference
    0.1%
    Check dated 2026-06-26T23:19:16.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Recruitment status updated to closed for the study. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading was standardized, and the site revision note updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:38:22.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page or its template. This update appears to be a metadata/versioning change rather than a modification to the study content or data presented.
    Difference
    0.1%
    Check dated 2026-06-05T12:15:28.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.5.3 to v3.5.4, indicating a small maintenance update to the page metadata rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T02:06:27.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a new build of the page in the revision history. This change is a metadata update with no impact on user-facing information.
    Difference
    0.1%
    Check dated 2026-04-30T15:50:04.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.